EF
RXDX

Empowered Funds’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Empowered Funds’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-39,890
Closed -$2.35M – 490
2022
Q3 		$2.35M Buy
+39,890
New +$2.35M 0.23% 103